Abstract:Baozhong Yu, Maolin Chen, Ye Zhang, Yudan Cao, Jun Yang, Bing Wei, Junyu Wang Emergency Medicine Clinical Research Center, Beijing Chao-Yang Hospital, Capital Medical University, & Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation, Clinical Center for Medicine in Acute Infection, Capital Medical University, Beijing, People's Republic of China Correspondence: Bing Wei; Junyu Wang, Emergency Medicine Clinical Research Center, Beijing Chao-Yang Hospital, Capital Medical University, & Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation, Clinical Center for Medicine in Acute Infection, Capital Medical University, Beijing, 100020, People's Republic of China, Email ; Purpose: The objective of this study was to explore the diagnostic and prognostic value of interleukin-6 (IL-6) in sepsis patients presenting to the emergency department. Patients and Methods: A total of 128 patients who visited the emergency department of West Hospital of Beijing Chaoyang Hospital, affiliated to Capital Medical University, from November 2021 to February 2022 were subjected to this study. According to Sepsis-3.0 diagnostic criteria for sepsis, patients were divided into non-sepsis group (65 cases) and sepsis group (63 cases). Demographic data and clinical characteristics of the two patient groups were compared. Serum levels of biomarkers including IL-6, blood urea nitrogen (BUN), and lactic acid (Lac) were compared with Sequential Organ Failure Assessment (SOFA) and Glasgow Coma Scale (GCS) scores. Logistic regression was used to analyze independent risk factors and Receiver Operating Characteristic Curve (ROC) method was used to analyze the Area Under the Curve (AUC) to determine the diagnostic and prognostic value of markers. Results: Compared with non-sepsis patients, levels of IL-6, PCT, CRP and BUN were significantly higher in sepsis patients (10.84 (4.41– 27.01): 92.22 (21.53– 201.12), 0.03 (0.01– 0.1):0.49 (0.08– 3.1), 8.3 (0.5– 31.8):39.8(10.3– 98.6), 7.01 (4.90– 11.74):13.03 (6.93– 25.99), all p = 0.001). IL-6, BUN and mean arterial pressure (MAP) were independent risk factors for sepsis diagnosis. AUC values of IL-6, BUN, MAP and IL-6+BUN+MAP were 0.764, 0.696, 0.685, and 0.848, respectively. Lactate, age and SOFA score were independent risk factors for 28-day mortality in sepsis patients. The AUC of Lac, age, SOFA score and Lac+age+SOFA score to predict 28-day death in sepsis patients was 0.679, 0.626, 0.747, and 0.819, respectively. Conclusion: IL-6 is an independent predictor of sepsis diagnosis, and the combination of blood BUN and MAP has superior diagnostic performance. Lac, age, and SOFA score could effectively predict clinical outcomes in patients with sepsis. Keywords: interleukin-6, emergency department, Lac, sepsis, SOFA score, mortality Sepsis is a complex disease syndrome characterized by disturbances in the body's immune, endocrine, and metabolic responses to infection that lead to multiple organ failure, shock, and death. According to the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3.0), defined sepsis as a life-threatening organ dysfunction caused by a dysregulated host response to infection. Despite advances in modern medicine, the mortality rate in patients with sepsis is still high, at an estimated 25–30%. 2 Therefore, early identification and diagnosis are crucial, as timely intervention and treatment can improve prognosis. Various biomarkers have been studied, including C-reactive protein (CRP) and procalcitonin (PCT), for the diagnosis of sepsis, but their diagnostic potential 3 and prognostic value 4 are limited. Therefore, new biomarkers or a combination of multiple markers need to be discovered for rapid diagnosis of sepsis and prediction of clinical outcomes. Sepsis is caused by a complex response to systemic inflammation driven by multiple elevated blood biomarkers, including immune cells and cytokines, such as White Blood Cell (WBC) and interleukin 6 (IL-6). This article aimed to determine the diagnostic value of IL-6 in sepsis and its association with 28-day mortality. In total, 128 critically ill patients who were admitted to the Emergency Department of West Hospital of Beijing Chaoyang Hospital Affiliated to Capital Medical University from November 2021 to February 2022 were subjected to this study. Pregnancy; patients with malignant tumors, hematological diseases, connective tissue diseases or receiving immunosuppressive therapy. This study complied with the Declaration of Helsinki. The research protocol was approved by Ethics Committee of Beijing Chaoyang Hospital Affiliated to Capital Medical University (approval number: 2021-ke-636). Informed consent was obtained from all patients or their familie -Abstract Truncated-

Role of Interleukin-6 and Interleukin-8 Cytokines as Early Diagnostic Markers of Sepsis

Utility of Cytokines to Predict Neonatal Sepsis.

Study on Levels of Serum IL-6 and IL-6 Mrna Expression in Neonatal Sepsis and Septic Shock

Recent advances in the biology of IL-1 family cytokines and their potential roles in development of sepsis.

Cytokines of serum related detection and significance in septic patients

[IL-6, IL-1β, and IL-10 Levels in Peripheral Blood As Indicators for Early Identification of Gram-Positive and Gram-Negative Sepsis].

Diagnostic Potential of Serum Interleukin-6 in Predicting Bacteremia in Adult Patients with Sepsis: A Prospective Observational Study

Differential expression of plasma cytokines in sepsis patients and their clinical implications

Utility of cytokine, adhesion molecule and acute phase proteins in early diagnosis of neonatal sepsis

Diagnostic and Prognostic Value of Interleukin-6 in Emergency Department Sepsis Patients

AME Evidence Series 001-the Society for Translational Medicine: Clinical Practice Guidelines for Diagnosis and Early Identification of Sepsis in the Hospital

Comparison between CRP and IL-6 as early markers of neonatal sepsis

Early diagnosis of bacterial infection in patients with septicopyemia by laboratory analysis of PCT, CRP and IL-6

Biomarkers in sepsis: the present and the future

The Prospective Analysis of Biomarkers in Sepsis: Correlation With Clinical Outcomes

Value of IL-6 and IL-8 in the Diagnosis of Neonatal Sepsis

Evaluating IL-6 and IL-10 as rapid diagnostic tools for Gram-negative bacteria and as disease severity predictors in pediatric sepsis patients in the intensive care unit

Diagnostic Values of Procalcitonin, Interleukin-6, C Reactive Protein and Serum Amyloid A in Sepsis

IL7R, GZMA and CD8A Serve As Potential Molecular Biomarkers for Sepsis Based on Bioinformatics Analysis

Identification of Key Inflammation-related Genes as Potential Diagnostic Biomarkers of Sepsis

Comparative Evaluation of PCT, CRP and IL-6 in Cases of Suspected Sepsis